PUBLIC COMPANY
save$KPTIKaryopharm Therapeutics Inc.
$KPTINewton, MA, USupdated 2mo ago
community read0 votes
pipeline
2
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Marketed1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- phase3Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
- phase3Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]
- phase3Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
- —Karyopharm Expanded Access Program for Selinexor
- phase2A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- phase2A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.
- phase2Selinexor and Backbone Treatments of Multiple Myeloma Patients
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 21, 26SELLRangwala Reshma· EVP & Chief Medical Officer−$4K↗
🐶 Hiring Signal
News
- Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra useKaryopharm bought an extra month to negotiate with creditors or pursue a deal. Elsewhere, BridgeBio Pharma’s oncology spinout shook up its development plans and a brain-focused gene therapy startup…biopharma_dive · 22d ago
- Karyopharm has a month left to salvage its cancer expansion plansA commercial-stage cancer drugmaker with a market cap about one-third the size of its projected 2026 revenues is on the brink of defaulting. Karyopharm Therapeutics said Thursday that it has until ...endpoints · 1mo ago
Data sources
last refreshed 24m ago
Found something off?
comments(0)
5-min edit window · permanent after that